Results 31 to 40 of about 520 (121)

Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma. [PDF]

open access: yesCancer Res Commun, 2022
Krytska K   +16 more
europepmc   +1 more source

Bioguided Isolation of Cyclopenin Analogues as Potential SARS-CoV-2 Mpro Inhibitors from Penicillium citrinum TDPEF34. [PDF]

open access: yesBiomolecules, 2021
Thissera B   +10 more
europepmc   +1 more source

Randomized Controlled Trial of the Gastrin/CCK2 Receptor Antagonist Netazepide in Patients with Barrett's Esophagus. [PDF]

open access: yesCancer Prev Res (Phila), 2021
Abrams JA   +12 more
europepmc   +1 more source

P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer. [PDF]

open access: yesJ Pathol, 2022
Maynard JP   +13 more
europepmc   +1 more source

Harnessing unprotected deactivated amines and arylglyoxals in the Ugi reaction for the synthesis of fused complex nitrogen heterocycles. [PDF]

open access: yesBeilstein J Org Chem
Gómez-Ayuso J   +5 more
europepmc   +1 more source

XMD8-92 and JWG-045 exhibit anti-ferroptotic activities, independently of inhibiting ERK5. [PDF]

open access: yesSci Rep
Zhang W   +10 more
europepmc   +1 more source

Meclonazepam sensitivity of parasitic flatworms correlates with TRPM<sub>MCLZ</sub> sensitivity to meclonazepam. [PDF]

open access: yesInt J Parasitol Drugs Drug Resist
Rohr CM   +11 more
europepmc   +1 more source

A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6. [PDF]

open access: yesJ Med Chem, 2021
Shen Y   +26 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy